Darunavir/Ritonavir and Rosuvastatin Pharmacokinetic Study

Categoría Estudio primario
Registro de estudiosClinicalTrials.gov
Año 2009
Cargando información sobre las referencias
This is a phase I, open-label, controlled drug interaction study to determine the effects of darunavir plus ritonavir on the pharmacokinetics of the hydroxymethylglutaryl coenzyme A (HMG-CoA) reductase inhibitor, rosuvastatin, in HIV-1-seronegative subjects.
Epistemonikos ID: b19f1b643160864bf5bb71bec2d77be4b92384e9
First added on: Dec 01, 2021